Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
About this item
Full title
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2023-07, Vol.389 (3), p.228-238
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this phase 1 study involving persons with hypertension, zilebesiran (an RNA interference therapeutic agent) was associated with decreases in angiotensin levels and systolic and diastolic blood pressure.
Alternative Titles
Full title
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2840246592
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2840246592
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2208391
